ناشر تخصصی کنفرانس های ایران

لطفا کمی صبر نمایید

Publisher of Iranian Journals and Conference Proceedings

Please waite ..
ناشر تخصصی کنفرانسهای ایران
ورود |عضویت رایگان |راهنمای سایت |عضویت کتابخانه ها
عنوان
مقاله

Common Concerns of Cancer Patients in the Time of COVID-۱۹ Outbreak: Some Implications for Health Care Professionals

سال انتشار: 1400
کد COI مقاله: JR_INJER-8-1_001
زبان مقاله: انگلیسیمشاهده این مقاله: 31
متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

خرید و دانلود فایل مقاله

متن کامل (فول تکست) این مقاله منتشر نشده و یا در سایت موجود نیست و امکان خرید آن فراهم نمی باشد.

مشخصات نویسندگان مقاله Common Concerns of Cancer Patients in the Time of COVID-۱۹ Outbreak: Some Implications for Health Care Professionals

Zohreh Shahhosseini - Department of Reproductive Health and Midwifery, Faculty of Nursing and Midwifery, Sexual and Reproductive Health Research Center, Mazandaran University of Medical Sciences, Sari, Iran
Fatemeh Hamidi - Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran

چکیده مقاله:

Dear Editor, Coronaviruses are important human and animal pathogens. In December ۲۰۱۹, a new virus from the coronavirus family, called coronavirus disease ۲۰۱۹ (COVID-۱۹), triggered the outbreak of pneumonia from Wuhan across China. The virus originated in bats and was transmitted to humans through unknown intermediate animals. Currently, the lives of millions of people around the world are affected by the crisis caused by the outbreak of COVID-۱۹ diseases, which has brought huge economic and social costs. Despite the efforts made in many countries to reduce the risks and the negative effects of this crisis, the damage and the resulting costs are still increasing. People with cancer are among the groups that need more attention and are highlighted as high-risk groups. The risk of morbidity and mortality from COVID-۱۹ as a consequence of severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲) infection is not uniform. Evidence show that patients with cancer have an increased risk of developing severe forms of COVID-۱۹ compared with the non-cancer population. It seems that cancer patients are at a higher risk of respiratory viruses such as influenza because of their frequently observed immunocompromised state. Patients with blood malignancies, such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, and multiple myeloma, along with those in active treatment for any type of cancer and people who have undergone bone marrow transplants are among the high-risk groups.   According to the existing literature on COVID-۱۹ pathogenesis and cancer, several shared features have been selected to define the risk assessment in cancer patients, including patient characteristics (such as older age, underlying diseases, obesity, and sex), disease characteristics, therapeutic characteristics, and clinical and laboratory variables. Given the competitive risks of cancer-related deaths and serious complications from SARS-CoV-۲ and higher mortality, providing care for cancer patients in this crisis is a challenging task. Many cancer patients are seeking to find a cure for their disease due to cancellation or delay in treatment, including surgery, chemotherapy, and radiation therapy. There are also concerns that patients with curable cancers, who need timely treatments, find the risk of COVID-۱۹ higher than the benefits of cancer treatment. New findings from researchers in the United States show that ۱۳% of patients, including cancer patients, who used a combination of azithromycin and hydroxychloroquine or just hydroxychloroquine for treatment died within one month. However, further testing is needed to determine the risks and benefits of these drugs. It has recently been reported that using a combination of the two drugs to treat cancer patients infected with COVID-۱۹ has tripled their risk of death within ۳۰ days. Hence, it is recommended that these patients do not use the mentioned drugs. Insufficient provision of personal protective equipment for health care providers, limited hospital capacity, including intensive care units, may be effective in providing care to people with cancer. Early treatment of cancer patients should not be compromised during the pandemic. However, patient management should be tailored to the best available resources, and the need for any intervention should be balanced against the increased risk of pandemic. In addition, alternative modified procedures, including counseling and treatment services such as home care and tele-nursing should be considered for cancer patients. The goals, alternative modified procedures, including counseling and treatment services, were to ensure the continuity of care and to protect the health care professionals from the infection. Health scholars in different disciplines have proposed another method to manage cancer patients; according to these scholars, in special circumstances, cyberspace like “WhatsApp”, “Telegram”, or “Instagram” should be used to communicate with patients and share educational materials and information. Moreover, training nurses to respond appropriately to patient needs, such as stress management and proper nutrition, is essential. Outpatients should be treated with the safest level of care and away from any danger. Several measures may help reduce the virus transmission as follows: training the proper communication rules and hand hygiene protocols, explaining infection control measures, teaching the signs and symptoms of COVID-۱۹, highlighting the importance of staying home and non-exposure to high-risk individuals, and emphasizing the importance of reporting any new symptoms to physicians and health care providers. Attendance at the clinic should be limited only to patients themselves and a maximum of one companion; in addition, outpatient care clinics, including chemotherapy injection units should have careful screening and be prepared to identify possible cases safely and without risk of transmission. Currently and due to the limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic, but for each patient, a separate decision should be made according to age, general condition, stage, and spread of the disease, and the patients should consult their physician about this issue. At present, more than ever, the world needs to espouse perspectives free of race, religion, ethnicity, and gender to help countries come together for the sake of the health of all populations. Community participation, attention to the health of all cancer patients in all age groups, non-discrimination, access to quality services and information, and appropriate collaboration can help in this regard.

کلیدواژه ها:

CORONA, Cancer, Health Care

کد مقاله/لینک ثابت به این مقاله

کد یکتای اختصاصی (COI) این مقاله در پایگاه سیویلیکا JR_INJER-8-1_001 میباشد و برای لینک دهی به این مقاله می توانید از لینک زیر استفاده نمایید. این لینک همیشه ثابت است و به عنوان سند ثبت مقاله در مرجع سیویلیکا مورد استفاده قرار میگیرد:

https://civilica.com/doc/1222977/

نحوه استناد به مقاله:

در صورتی که می خواهید در اثر پژوهشی خود به این مقاله ارجاع دهید، به سادگی می توانید از عبارت زیر در بخش منابع و مراجع استفاده نمایید:
Shahhosseini, Zohreh and Hamidi, Fatemeh,1400,Common Concerns of Cancer Patients in the Time of COVID-۱۹ Outbreak: Some Implications for Health Care Professionals,https://civilica.com/doc/1222977

در داخل متن نیز هر جا که به عبارت و یا دستاوردی از این مقاله اشاره شود پس از ذکر مطلب، در داخل پارانتز، مشخصات زیر نوشته می شود.
برای بار اول: (1400, Shahhosseini, Zohreh؛ Fatemeh Hamidi)
برای بار دوم به بعد: (1400, Shahhosseini؛ Hamidi)
برای آشنایی کامل با نحوه مرجع نویسی لطفا بخش راهنمای سیویلیکا (مرجع دهی) را ملاحظه نمایید.

مدیریت اطلاعات پژوهشی

صدور گواهی نمایه سازی | گزارش اشکال مقاله | من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

اطلاعات استنادی این مقاله را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

علم سنجی و رتبه بندی مقاله

مشخصات مرکز تولید کننده این مقاله به صورت زیر است:
نوع مرکز: دانشگاه دولتی
تعداد مقالات: 9,311
در بخش علم سنجی پایگاه سیویلیکا می توانید رتبه بندی علمی مراکز دانشگاهی و پژوهشی کشور را بر اساس آمار مقالات نمایه شده مشاهده نمایید.

به اشتراک گذاری این صفحه

اطلاعات بیشتر درباره COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.

پشتیبانی